Dr. Mitchell Glass MD

Council Member Biography

Mitchell Glass, MD, is a Consultant to start-up pharmaceutical and device companies. He is currently CEO and Director of AVATAR Biosystems. Dr. Glass was previously Senior Vice President and Chief Scientific Officer of the University City Science Center in Philadelphia, where he was responsible for identifying, evaluating, and commercializing promising technologies. Prior to joining the Science Center, Dr. Glass was President and Director of geneRx+, a privately held research-stage gene therapy company that included alpha-1 antitrypsin deficiency as its primary target. From 1997 to 2002, Dr. Glass was Chief Medical Officer for AtheroGenics, Inc. He also served as Vice President and Director of Cardiopulmonary Clinical Research, Development and Medical Affairs at SmithKline Beecham where through 1996 he supervised the company’s development portfolio in cardiovascular, pulmonary metabolic, and renal diseases. Prior to that, Dr. Glass developed the Pulmonary Therapeutics division of ICI Pharmaceuticals (which later became Zeneca) in Wilmington, Delaware. (This is me - Update Profile)

Employment History

2008 - Unspecified

Consultant, Mitchell Glass

2008 - Unspecified

Consultant, LLuminari

2005 - 2008

CEO and Director, Aqumen Biopharmaceuticals KK

1997 - 2002

Vice President, AtheroGenics Inc.